Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.
Darren R HargraveKeita TerashimaJunichi HaraUwe R KordesSanthosh A UpadhyayaFelix SahmEric BouffetRoger J PackerOlaf WittLarissa SandalicAgnieszka KielochMark RussoKenneth J Cohennull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
V600-mutant HGG.